CaroGen Company

CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.
Technology: Viral Vectors
Industry: Viral Vectors
Headquarters: Hamden, Connecticut, United States
Founded Date: 2012-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 2
Total Funding: 90700000
Estimated Revenue: Less than $1M
Last Funding Date: 2019-03-27
Last Funding Type: Grant

Visit Website
Register and Claim Ownership